Bill Meagher's focus with The Deal is on small and microcap equity finance, healthcare and biotechnology, PIPEs, and companies going public. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization and ghost written two books.
Recent Articles By The Author
19 Dead, More Than 50 Seriously Injured in Possible Terror Bombing at U.K. Concert
Officials say incident is being treated as a suicide bombing; witnesses say explosion so powerful 'the ground shook.'
Aduro Biotech, Merck Team on Cancer Drug Trial
Aduro Biotech and Merck will team on two separate trials featuring Aduro's CRS-207 and Merck's Keytruda to explore treatments for mesothelioma and gastric cancer.
Amgen Reports Mixed Financials Results as Its Lead Drug, Enbrel, Sees Sales Decrease
The drug company maintained its 2017 guidance, but sales of two of its key drugs registered disappointing results, and shares were down in after-hours trading 3%.
United's Skies Aren't Too Friendly These Days
United needn't worry about fare wars as long as it keeps making public gaffes as a video of a passenger being dragged off a flight goes viral.
Private Prisons Break Out Under Trump
While the Obama administration wanted to unload for-profit-prison contracts, CoreCivic and the Geo Group have seen their stock explode since Trump took office.